SECONDARY STROKE PREVENTION IN PEOPLE WITH ATRIAL FIBRILLATION - THE CARDIOLOGIST'S PERSPECTIVE

Our Faculty

Prof. Derek Connolly

BSc.(Hons), MB.ChB.(Edin), PhD.(Cantab), FRCP

• Dr Derek Connolly is a Consultant Interventional Cardiologist at Birmingham City Hospital (UK) and an Honorary Senior Clinical Lecturer, at the Institute of Cardiovascular Sciences, University of Birmingham.
• His main clinical and research interest is the detection and treatment of coronary heart disease.
• He was appointed to his current role in Birmingham in 2000 and has been integral to the early development of both primary angioplasty and cardiac CT programs. He was UK Chief Investigator for the Fourier and Ebbinghaus Trials in cholesterol reduction and has been an investigator in over 30 large landmark trials in the field of cardiovascular disease research.
• Dr Connolly is a sought-after speaker and has presented to conferences in over 50 cities worldwide. He is a Senior Academy Teacher at the University of Birmingham Medical School.
• He was recently co-opted to the committee of the Primary Care Cardiovascular Society and has a large role in the education of Primary Care physicians.
• He is keen to provide the latest evidence based, state of the art tests and treatments that he would want for his family and friends.

Prof (Dr). JPS Sawhney

MBBS, MD, DM: PGI Chandigarh, FACC, FESC, FRCP

• Sr. Consultant Cardiologist & Chairman, Department of Cardiology, Sir Ganga Ram Hospital, New Delhi, India.
• Member Board of Management, Executive board, Ethics & Research Committee, SGRH.
• Ex Member of Delhi Medical Council.
• Past Chairman of Lipid Council of India (CSI).
• More than 212 National and International publications in Indexed journals and reputed books.
• National coordinator, steering committee member and PI of many global trials and registries.
• He has received various National Awards and Orations.

Dr. Jamshed Dalal

MBBS, MD (Gen Medicine), DM (Cardiology), PhD (Cardiology), FESC, FRCP(London)

• Director, Cardiac Sciences, Kokilaben Hospital, Mumbai
• First coronary angiography in UK in 1978 and since then has done more than20000 cases over 35 years.
• 40 years of experience after completion of DM in cardiology. Five years trainingabroad.
• Course Director and speaker at hundreds of Cardiology conferences over the past30 years.
• 73+ National and international journals.

EXPECTED OUTCOMES

This symposium aims to provide a comprehensive understanding of secondary stroke prevention in patients with atrial fibrillation, encompassing both pharmacological and non-pharmacological strategies and determining when to switch to NOACs, comparing their bleeding risks. Learners will gain in-depth insights into the optimal timing and frequency for diagnosing and intervening in AF patients post-ischemic stroke. Additionally, participants will receive an overview of the challenges of diagnosing NVAF in post-stroke patients, the use of AF detecting patches or Holter monitors, and the importance of multidisciplinary management in preventing secondary strokes.

LEARNING OBJECTIVES

• Understand current recommendations for the detection of atrial fibrillation in patients after an ischaemic stroke
• Gain insight into the optimal timing and methods for AF detection to ensure timely diagnosis and intervention - Holter - AF Patch.
• The AF-CARE pathway, comorbidity and risk factor management, stroke and thromboembolism prevention, symptom reduction through rate and rhythm control, and dynamic patient evaluation and reassessment.
• Selecting appropriate oral anticoagulation, antiplatelet, and combination therapy based on clinical scenarios and bleeding risk
• Understand when to switch to NOAC Myths and challenges around anticoagulation in atrial fibrillation Role of anticoagulation in low-risk patients with AF and its impact on stroke and cognitive function
• Role of anticoagulation in low-risk patients with AF and its impact on stroke and cognitive function
• Discuss the risk of venous thromboembolism in patients with AF and the importance of early anticoagulation in reducing the symptom burden in these patients

Agenda

Copyright: All rights reserved. No part of this website content may be reproduced, stored in retrieval system, tapes, discs, microfilms etc., or transmitted in any form or by any means electronic, mechanical, photocopies, recording or otherwise, without the written permission of Insignia Learning Pvt. Ltd., Mumbai.